Pharm/Biopharm Manufacturing Support
Small and Large Molecule Manufacturing Support.
Pharm/Biopharm Development Testing
Small and Large Molecule Development Support.
Clinical Trial Support
Immunogenicity and Bioanalysis for Clinical Trials.
Medical Device Tests
Medical Device, Delivery Device, and Combination Product Services.
CLIENT PORTAL
The Power of My PBL
Access your reports, study and submission status, invoices, quotes and purchase order information all at one secure location on the web.
News
March 27, 2019
PBL Is Now ISO 17025:2017 Accredited
Pacific BioLabs is proud to announce successful accreditation for ISO 17025:2017, General Requirements for the Competence of Testing and Calibration Laboratories, through the ANSI-ASQ National Accreditation Board. PBL’s accreditation for ISO 17025:2017 replaces PBL’s past certifications for ISO 9001:2008 and ISO 13485:2003 and is considered more appropriate for a CRO. The scope for PBL’s 17025 […]
March 26, 2019
Pacific BioLabs featured in MPO’s article – Transformative Testing: Addressing Patient Safety and Cybersecurity
For their March issue, Medical Product Outsourcing Magazine interviewed Ryan Harper, PBL’s Business Development Director, regarding recent medical device testing changes and developments. The article discusses current industry trends, additions to ISO 10993, performing risk assessments as well as new technologies and approaches. The MPO article can be accessed here.
December 11, 2018
Erik Foehr, VP of Analytical Chemistry, Interviewed on Raw Material Testing
PBL’s Vice President of Analytical Chemistry was interviewed by BioPharm International for an article titled, Analytical Best Practices for Raw Material Testing. Pacific BioLabs performs testing on raw materials for many different clients. Please contact PBL for your raw material testing needs. The BioPharm International article can be found here.
Trade Shows and Events
June 3-6th, 2019 | Philadelphia, PA
BIO
The BIO International Convention attracts over 16,000 biotech and pharmaceutical leaders from over 7,000 companies. Sessions span a wide spectrum including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy. The unique one-on-one partnering system provide a great way to meet new vendors, partners and investors.